ESR2 and cancer: In some of these cancers, ERβ levels decline in close correlation with the development of less differentiated phenotype [43], [45], [46], which correlates well with our previous finding of nuclear ERβ in well-differentiated desmoplastic and neuroblastic medulloblastoma [9].